RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae.

The numerous regulatory roles of cellular RNAs suggest novel potential drug targets, but establishing intracellular drug-RNA interactions is challenging. Cisplatin (cis-diamminedichloridoplatinum(II)) is a leading anticancer drug that forms exchange-inert complexes with nucleic acids, allowing its distribution on cellular RNAs to be followed ex vivo. Although Pt adduct formation on DNA is well-known, a complete characterization of cellular RNA-Pt adducts has not been performed. In this study, the action of cisplatin on S. cerevisiae in minimal media was established with growth curves, clonogenic assays, and tests for apoptotic markers. Despite high toxicity, cisplatin-induced apoptosis in S. cerevisiae was not observed under these conditions. In-cell Pt concentrations and Pt accumulation on poly(A)-mRNA, rRNA, total RNA, and DNA quantified via ICP-MS indicate ∼4- to 20-fold more Pt accumulation in total cellular RNA than in DNA. Interestingly, similar Pt accumulation is observed on rRNA and total RNA, corresponding to one Pt per (14,600 ± 1,500) and (5760 ± 580) nucleotides on total RNA following 100 and 200 μM cisplatin treatments, respectively. Specific Pt adducts mapped by primer extension analysis of a solvent-accessible 18S rRNA helix occur at terminal and internal loop regions and appear as soon as 1 h post-treatment. Pt per nucleotide accumulation on poly(A)-mRNA is 4- to 6-fold lower than on rRNA but could have consequences for low copy-number or highly regulated transcripts. Taken together, these data demonstrate significant accumulation of Pt adducts on cellular RNA species following in cellulo cisplatin treatment. These and other small molecule-RNA interactions could disrupt processes regulated by RNA.

[1]  P. Lord,et al.  Dependency of size of Saccharomyces cerevisiae cells on growth rate , 1979, Journal of bacteriology.

[2]  Y. Tor.  Targeting RNA with Small Molecules , 2003, Chembiochem : a European journal of chemical biology.

[3]  M. Arno,et al.  Genomic Screening in Vivo Reveals the Role Played by Vacuolar H+ ATPase and Cytosolic Acidification in Sensitivity to DNA-Damaging Agents Such as Cisplatin , 2007, Molecular Pharmacology.

[4]  K. Akuta,et al.  The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal Concentration , 1992, Japanese journal of cancer research : Gann.

[5]  Devis Sinani,et al.  Distinct Mechanisms for Ctr1-mediated Copper and Cisplatin Transport* , 2007, Journal of Biological Chemistry.

[6]  Elizabeth C. Theil,et al.  The up-regulation of ferritin expression using a small-molecule ligand to the native mRNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Meisinger,et al.  Apoptosis in yeast: triggers, pathways, subroutines , 2010, Cell Death and Differentiation.

[8]  Eleonore Fröhlich,et al.  A Yeast Mutant Showing Diagnostic Markers of Early and Late Apoptosis , 1997, The Journal of cell biology.

[9]  Thomas D. Schmittgen,et al.  Inhibition of pre-mRNA splicing by cisplatin and platinum analogs. , 2003, International journal of oncology.

[10]  Christiane Branlant,et al.  Identification of modified residues in RNAs by reverse transcription-based methods. , 2007, Methods in enzymology.

[11]  A. Jetzt,et al.  Ricin A-chain requires c-Jun N-terminal kinase to induce apoptosis in nontransformed epithelial cells. , 2009, The international journal of biochemistry & cell biology.

[12]  Ronald T. Raines,et al.  Ribonucleases as Novel Chemotherapeutics , 2012, BioDrugs.

[13]  H. Burger,et al.  A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin. , 2000, Biochemical and biophysical research communications.

[14]  P. Sato,et al.  Cisplatin inhibits in vitro translation by preventing the formation of complete initiation complex. , 1993, Molecular pharmacology.

[15]  J. Mattick.  RNA regulation: a new genetics? , 2004, Nature Reviews Genetics.

[16]  R. Moses,et al.  Cisplatin DNA cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccharomyces cerevisiae. , 1999, Mutation research.

[17]  Bing Zhou,et al.  Copper and manganese induce yeast apoptosis via different pathways. , 2007, Molecular biology of the cell.

[18]  A. Bergamo,et al.  Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin , 2003, Investigational New Drugs.

[19]  R. Hoffmann.  The effect of cisplatin and platinum(IV)chloride on cell growth, RNA, protein, ribosome and DNA synthesis in yeast , 1988 .

[20]  Nan Yu,et al.  The Comparative RNA Web (CRW) Site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs , 2002, BMC Bioinformatics.

[21]  F. Rodrigues,et al.  Drug-induced apoptosis in yeast. , 2008, Biochimica et biophysica acta.

[22]  A. Hopper,et al.  tRNA biology charges to the front. , 2010, Genes & development.

[23]  J. Warner,et al.  The economics of ribosome biosynthesis in yeast. , 1999, Trends in biochemical sciences.

[24]  F. Zunino,et al.  Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells. , 2004, Biochemical pharmacology.

[25]  M. Dietel,et al.  Involvement of the DNA mismatch repair system in antineoplastic drug resistance , 1999, Journal of Cancer Research and Clinical Oncology.

[26]  N. Tumer,et al.  Ribosome Depurination Is Not Sufficient for Ricin-Mediated Cell Death inSaccharomyces cerevisiae , 2006, Infection and Immunity.

[27]  P. Dyson,et al.  Metal-based antitumour drugs in the post genomic era. , 2006, Dalton transactions.

[28]  Stephan J. Sigrist,et al.  Oxygen Stress: A Regulator of Apoptosis in Yeast , 1999, The Journal of cell biology.

[29]  C. Mazzoni,et al.  mRNA stability and control of cell proliferation. , 2011, Biochemical Society transactions.

[30]  Mariël Brok,et al.  Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill. , 2003, Molecular pharmacology.

[31]  K. Fröhlich,et al.  Yeast apoptosis--from genes to pathways. , 2007, Seminars in cancer biology.

[32]  T. Boulikas,et al.  Cisplatin and platinum drugs at the molecular level. (Review). , 2003, Oncology reports.

[33]  T. Jacks,et al.  p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Zisowsky,et al.  Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. , 2007, Biochemical pharmacology.

[35]  I. Herskowitz,et al.  Genetic Analysis of Cisplatin Resistance in Yeast and Mammals , 2007 .

[36]  Q. Ju,et al.  Ribosome synthesis during the growth cycle of Saccharomyces cerevisiae , 1994, Yeast.

[37]  S. Elmroth,et al.  Platination of full length tRNA(Ala) and truncated versions of the acceptor stem and anticodon loop. , 2008, Dalton transactions.

[38]  J. Perez,et al.  Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. , 2003, Current medicinal chemistry.

[39]  K. Shirahige,et al.  Glucose‐dependent cell size is regulated by a G protein‐coupled receptor system in yeast Saccharomyces cerevisiae , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[40]  Erich G. Chapman,et al.  Enzymatic processing of platinated RNAs. , 2010, Journal of the American Chemical Society.

[41]  C. Sorenson,et al.  Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. , 1988, Cancer research.

[42]  Michael Gribskov,et al.  Characterization of the yeast ionome: a genome-wide analysis of nutrient mineral and trace element homeostasis in Saccharomyces cerevisiae , 2005, Genome Biology.

[43]  Rob Phillips,et al.  SnapShot: Key Numbers in Biology , 2010, Cell.

[44]  N. Zhang,et al.  Nonapoptotic Death of Saccharomyces cerevisiae Cells That Is Stimulated by Hsp90 and Inhibited by Calcineurin and Cmk2 in Response to Endoplasmic Reticulum Stresses , 2008, Eukaryotic Cell.

[45]  Christopher A. Lepre,et al.  Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNA , 1990 .

[46]  R. Matts,et al.  Cisplatin inhibits protein synthesis in rabbit reticulocyte lysate by causing an arrest in elongation. , 1997, Archives of biochemistry and biophysics.

[47]  F. Sherman.  Getting started with yeast. , 1991, Methods in enzymology.

[48]  Paul J Hergenrother,et al.  Targeting RNA with small molecules. , 2008, Chemical reviews.

[49]  S. Peltz,et al.  The cap-to-tail guide to mRNA turnover , 2001, Nature Reviews Molecular Cell Biology.

[50]  Stephen J Lippard,et al.  Direct cellular responses to platinum-induced DNA damage. , 2007, Chemical reviews.

[51]  Nektarios Tavernarakis,et al.  Necrosis in yeast , 2010, Apoptosis.

[52]  C. Lin,et al.  Oxidative damage to RNA: mechanisms, consequences, and diseases , 2010, Cellular and Molecular Life Sciences.

[53]  S. Lippard,et al.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.

[54]  Phillip A Sharp,et al.  The Centrality of RNA , 2009, Cell.

[55]  B. Maden,et al.  Mapping 2'-O-methyl groups in ribosomal RNA. , 2001, Methods.

[56]  Christine S. Chow,et al.  A Structural Basis for RNA−Ligand Interactions , 1997 .

[57]  Z. Siddik,et al.  Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. , 2004, Molecular cancer therapeutics.

[58]  J. Turnay,et al.  Cytotoxic mechanism of the ribotoxin α‐sarcin , 2001 .